Skip to main content
SpringerLink
Log in

Iodinated Contrast Agents for Cardiac CT

  • Chapter
Cardiac PET and PET/CT Imaging

Abstract

Cardiac computed tomography (CT) is a noninvasive imaging test that requires the use of intravenously administered contrast material and high-resolution, high-speed CT machinery to obtain detailed volumetric images of cardiac anatomy, coronary circulation, and great vessels. Most contrast-enhanced CT examinations in the West are performed with nonionic iodinated contrast media. However, adverse events still exist and consist of allergylike contrast reactions, chemo- or osmotoxic contrast reaction, contrast media-induced nephropathy, injection-related adverse events, and complications due to various coexisting conditions. Identification of patients at risk for developing contrast media reactions is likely to prevent serious adverse events and to enhance safety. Likewise, appropriate management strategies can be adopted to reduce morbidity and mortality associated with adverse reactions of iodinated contrast media used in cardiac CT scanning.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. McClennan BL, Stolberg HO. Intravascular contrast media: ionic versus nonionic-current status. Radiol Clin North Am. 1991;29:437–454.

    PubMed  CAS  Google Scholar 

  2. Spencer CM, Goa KL. Iodixanol: a review of its pharmacodynamic and pharmacokinetic properties and diagnostic use as an x-ray contrast medium. Drugs. 1996;52:899–927.

    Article  PubMed  CAS  Google Scholar 

  3. Maddox TG. Adverse reactions to contrast material: recognition, prevention, and treatment. Am Fam Physician. 2002;66:1229–1234.

    PubMed  Google Scholar 

  4. Cohan RH, Ellis JH. Iodinated contrast material in uroradiology. Choice of agent and management of complications. Urol Clin North Am. 1997;24:471–491.

    Article  PubMed  CAS  Google Scholar 

  5. Mortelé KJ, Oliva MR, Ondategui S, Ros PR, Silverman SG. Universal use of nonionic iodinated contrast medium for CT: evaluation of safety in a large urban teaching hospital. AJR Am J Roentgenol. 2005;184:31–34.

    PubMed  Google Scholar 

  6. Cohan RH, Matsumoto JS, Quagliano PV. Committee on Drugs and Contrast Media. Manual on Contrast Media. 5th ed. Reston, VA: American College of Radiology; 2004.

    Google Scholar 

  7. Webb JA, Stacul F, Thomsen HS, Morcos SK. Members of the Contrast Media Safety Committee of the European Society of Urogenital Radiology. Late adverse reactions to intravascular iodinated contrast media. Eur Radiol. 2003;13:181–184.

    Article  PubMed  Google Scholar 

  8. ESUR-European Society of Urogenital Radiology Contrast Media Safety Committee. Guidelines on Contrast Media. Version 4.0. 2004.

    Google Scholar 

  9. Tublin ME, Murphy ME, Tessler FN. Current concepts in contrast media-induced nephropathy. AJR Am J Roentgenol. 1998;171:933–939.

    PubMed  CAS  Google Scholar 

  10. Morcos SK, Thomsen HS, Webb JA. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol. 1999;9:1602–1613.

    Article  PubMed  CAS  Google Scholar 

  11. Ashley JB, Millward SF. Contrast agent-induced nephropathy: a simple way to identify patients with preexisting renal insufficiency. AJR Am J Roentgenol. 2003;181:451–454.

    PubMed  Google Scholar 

  12. Morcos SK. Contrast media-induced nephrotoxicity-questions and answers. Br J Radiol. 1998;71:357–365.

    PubMed  CAS  Google Scholar 

  13. Thomsen HS. Guidelines for contrast media from the European Society of Urogenital Radiology. AJR Am J Roentgenol. 2003;181:1463–1471.

    PubMed  Google Scholar 

  14. Waybill MM, Waybill PN. Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol. 2001;12:3–9.

    Article  PubMed  CAS  Google Scholar 

  15. Bostom AG, Kronenberg F, Ritz E. Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. J Am Soc Nephrol. 2002;13:2140–2144.

    Article  PubMed  CAS  Google Scholar 

  16. Guru V, Fremes SE. The role of N-acetylcysteine in preventing radiographic contrastinduced nephropathy. Clin Nephrol. 2004;62:77–83. Review.

    PubMed  CAS  Google Scholar 

  17. Sandler CM. Contrast-agent-induced acute renal dysfunction-is iodixanol the answer? N Engl J Med. 2003;348:551–553.

    Article  PubMed  Google Scholar 

  18. Erdogan A, Davidson CJ. Recent clinical trials of iodixanol. Rev Cardiovasc Med. 2003; 4(suppl 5):S43–S50.

    PubMed  Google Scholar 

  19. Tadros GM, Malik JA, Manske CL, et al. Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease. J Invasive Cardiol. 2005;17:211–215.

    PubMed  Google Scholar 

  20. Bellin MF, Jakobsen JA, Tomassin I, et al. Contrast Media Safety Committee of the European Society of Urogenital Radiology. Contrast medium extravasation injury: guidelines for prevention and management. Eur Radiol. 2002;12:2807–2812.

    Article  PubMed  Google Scholar 

  21. Johansen JG. Assessment of a non-ionic contrast medium (Amipaque) in the gastrointestinal tract. Investigative Radiology. 1978;13:523–527.

    Article  PubMed  CAS  Google Scholar 

  22. Raisanen J, Shapiro B, Glazer GM, et al. Plasma catecholamines in pheochromocytoma: effect of urographic contrast media. AJR Am J Roentgenol. 1984;143:43–46.

    PubMed  CAS  Google Scholar 

  23. Mukherjee JJ, Peppercorn PD, Reznek RH, et al. Pheochromocytoma: effect of nonionic contrast medium in CT on circulating catecholamine levels. Radiology. 1997;202: 227–231.

    PubMed  Google Scholar 

  24. Van Der Molen AJ, Thomsen HS, Morcos SK. Effect of iodinated contrast media on thyroid function in adults. Eur Radiol. 2004;14:902–907.

    Article  PubMed  Google Scholar 

  25. Rao VM, Rao AK, Steiner RM, et al. The effect of ionic and nonionic contrast media on the sickling phenomenon. Radiology. 1982;144:291–293.

    PubMed  CAS  Google Scholar 

  26. Losco P, Nash G, Stone P, Ventre J. Comparison of the effects of radiographic contrast media on dehydration and filterability of red blood cells from donors homozygous for hemoglobin A or hemoglobin S. Am J Hematol. 2001;68:149–158.

    Article  PubMed  CAS  Google Scholar 

  27. Cademartiri F, Mollet NR, van der Lugt A, et al. Intravenous contrast material administration at helical 16-detector row CT coronary angiography: effect of iodine concentration on vascular attenuation. Radiology. 2005;236:661–665.

    Article  PubMed  Google Scholar 

  28. Lawler LP, Pannu HK, Fishman EK. MDCT evaluation of the coronary arteries, 2004: how we do it-data acquisition, postprocessing, display, and interpretation. AJR Am J Roentgenol. 2005;184:1402–1412.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

    M. Raquel Oliva MD (Fellow in Radiology)

  2. CME Department of Radiology, Brigham and Women’s Hospital, Boston, MA, USA

    Koenraad J. Mortele MD (Associate Professor of Radiology, Harvard Medical School, Associate Director Division of Abdominal Imaging and Intervention, Director, Abdominal and Pelvic MRI, Director)

Authors
  1. M. Raquel Oliva MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Koenraad J. Mortele MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Harvard Medical School, Boston, Massachusetts, USA

    Marcelo F. Di Carli MD (Chief of Nuclear Medicine, Co-Director of Cardiovascular Imaging, Brigham and Women’s Hospital, Associate Professor of Radiology and Medicine) (Chief of Nuclear Medicine, Co-Director of Cardiovascular Imaging, Brigham and Women’s Hospital, Associate Professor of Radiology and Medicine)

  2. Department of Radiology, Harvard Medical School, Boston, Massachusetts, USA

    Martin J. Lipton MD, FACR, FACC (Director of Education, Non-Invasive Imaging, Brigham and Women’s Hospital, Professor of Radiology) (Director of Education, Non-Invasive Imaging, Brigham and Women’s Hospital, Professor of Radiology)

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Oliva, M.R., Mortele, K.J. (2007). Iodinated Contrast Agents for Cardiac CT. In: Di Carli, M.F., Lipton, M.J. (eds) Cardiac PET and PET/CT Imaging. Springer, New York, NY. https://doi.org/10.1007/978-0-387-38295-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-38295-1_6

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-35275-6

  • Online ISBN: 978-0-387-38295-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation